- Home
- PCRX vs GFR Comparison
PCRX vs GFR Comparison
Compare PCRX & GFR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PCRX
- GFR
- Stock Information
- Founded
- PCRX 2006
- GFR 2018
- Country
- PCRX United States
- GFR Canada
- Employees
- PCRX N/A
- GFR N/A
- Industry
- PCRX Biotechnology: Pharmaceutical Preparations
- GFR
- Sector
- PCRX Health Care
- GFR
- Exchange
- PCRX Nasdaq
- GFR Nasdaq
- Market Cap
- PCRX 604.7M
- GFR 489.7M
- IPO Year
- PCRX 2011
- GFR N/A
- Fundamental
- Price
- PCRX $18.98
- GFR $6.09
- Analyst Decision
- PCRX Buy
- GFR Buy
- Analyst Count
- PCRX 10
- GFR 1
- Target Price
- PCRX $26.60
- GFR $10.50
- AVG Volume (30 Days)
- PCRX 933.0K
- GFR 104.7K
- Earning Date
- PCRX 11-06-2024
- GFR 02-14-2025
- Dividend Yield
- PCRX N/A
- GFR N/A
- EPS Growth
- PCRX N/A
- GFR N/A
- EPS
- PCRX N/A
- GFR 0.40
- Revenue
- PCRX $694,957,000.00
- GFR $551,353,492.00
- Revenue This Year
- PCRX $4.94
- GFR $35.03
- Revenue Next Year
- PCRX N/A
- GFR $37.50
- P/E Ratio
- PCRX N/A
- GFR $15.16
- Revenue Growth
- PCRX 4.40
- GFR 11.20
- 52 Week Low
- PCRX $11.16
- GFR $4.68
- 52 Week High
- PCRX $35.95
- GFR $8.16
- Technical
- Relative Strength Index (RSI)
- PCRX 54.07
- GFR 25.40
- Support Level
- PCRX $18.73
- GFR $6.28
- Resistance Level
- PCRX $20.34
- GFR $7.33
- Average True Range (ATR)
- PCRX 1.13
- GFR 0.26
- MACD
- PCRX -0.03
- GFR -0.09
- Stochastic Oscillator
- PCRX 64.09
- GFR 8.82
About PCRX Pacira BioSciences Inc.
Pacira BioSciences Inc is a provider of non-opioid pain management and regenerative health solutions dedicated to advancing and improving outcomes for healthcare practitioners and their patients. The company has three commercialized non-opioid treatments: EXPAREL a long-acting, local analgesic currently approved for postsurgical pain management; ZILRETTA, an extended-release, intra-articular, corticosteroid injection indicated for the management of osteoarthritis; iovera, a novel, handheld device for delivering immediate, long-acting, drug-free pain control using precise, controlled doses of cold temperature to a targeted nerve.
About GFR Greenfire Resources Ltd.
Greenfire Resources Ltd explores, acquires, develops and produces oil and gas in the Canadian energy sector and internationally. Greenfire currently has two producing oil sand assets, Hangingstone Expansion and Hangingstone Demo. The Company has one reportable operating segment which is made up of its oil sands operations based on geographic location : Athabasca oil sands region of Alberta, Canada, nature of the products sold and integration of facilities and operations.